Biora Therapeutnew 001 Stock Shares Outstanding

4ZU0 Stock   5.10  0.00  0.00%   
BIORA THERAPEUTNEW 001 fundamentals help investors to digest information that contributes to BIORA THERAPEUTNEW's financial success or failures. It also enables traders to predict the movement of BIORA Stock. The fundamental analysis module provides a way to measure BIORA THERAPEUTNEW's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIORA THERAPEUTNEW stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BIORA THERAPEUTNEW 001 Company Shares Outstanding Analysis

BIORA THERAPEUTNEW's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, BIORA THERAPEUTNEW 001 has 0.0 of shares currently outstending. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The shares outstanding for all Germany stocks is 100.0% higher than that of the company.

BIORA Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIORA THERAPEUTNEW's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIORA THERAPEUTNEW could also be used in its relative valuation, which is a method of valuing BIORA THERAPEUTNEW by comparing valuation metrics of similar companies.
BIORA THERAPEUTNEW is currently under evaluation in shares outstanding category among its peers.

About BIORA THERAPEUTNEW Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BIORA THERAPEUTNEW 001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIORA THERAPEUTNEW using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIORA THERAPEUTNEW 001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in BIORA Stock

BIORA THERAPEUTNEW financial ratios help investors to determine whether BIORA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIORA with respect to the benefits of owning BIORA THERAPEUTNEW security.